Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil
Endovia Health Sciences, Inc. (NYSE:EDVA) ("Endovia" or the "Company"), an emerging cannabinoid-based health sciences company, today welcomed recent developments in the federal marijuana rescheduling